G73 | ´Þ¸® ºÐ·ùµÈ Áúȯ¿¡¼ÀÇ ±ÙÀ°½Å°æÀÌÇàºÎ ¹× ±ÙÀ°ÀÇ Àå¾Ö | Disorders of myoneural junction and muscle in diseases classified elsewhere |
 |
G730 | ³»ºÐºñ¼º Áúȯ¿¡¼ÀÇ ±Ù¹«·ÂÁõÈıº | Myasthenic syndromes in endocrine diseases |
 |
G730 | ´ç´¢º´¼º ±ÙÀ§Ãà¿¡¼ÀÇ ±Ù¹«·ÂÁõÈıº (4´ÜÀ§ ¼ýÀÚ .4¿¡ ÇØ´çµÇ´Â E10-E14+) | Myasthenic syndromes in diabetic amyotrophy(E10-E14+ ¿¡¼ .4) |
 |
G730 | °©»ó¼±µ¶Áõ[°©»ó¼±±â´ÉÇ×ÁøÁõ]¿¡¼ÀÇ ±Ù¹«·ÂÁõÈıº | Myasthenic syndromes in thyrotoxicosis[hyperthyroidism](E05.-+) |
 |
G731 | ÀÌÆ°-¶÷º£¸£Æ® ÁõÈıº | Eaton-Lambert syndrome(C00-D48+) |
 |
G732 | ½Å»ý¹°Áúȯ¿¡¼ÀÇ ±âŸ ±Ù¹«·ÂÁõÈıº | Other myasthenic syndromes in neoplastic disease (C00-D48+) |
 |
G733 | ´Þ¸® ºÐ·ùµÈ ±âŸ Áúȯ¿¡¼ÀÇ ±Ù¹«·ÂÁõÈıº | Myasthenic syndromes in other diseases classified elsewhere |
 |
G734 | ´Þ¸® ºÐ·ùµÈ °¨¿°¼º ¹× ±â»ýÃæ¼º Áúȯ¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in infectious and parasitic diseases classified elsewhere |
 |
G735 | ³»ºÐºñ¼º Áúȯ¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in endocrine diseases |
 |
G735 | ºÎ°©»ó±â´ÉÇ×ÁøÁõ¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in hyperparathyrodism(E21.0-E213+) |
 |
G735 | ºÎ°©»ó¼±±â´ÉÀúÇÏÁõ¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in hypoparathyroidism(E20.-+) |
 |
G735 | °©»ó¼±µ¶¼º ±Ùº´Áõ | Thyrotoxic myopathy (E05.-+) |
 |
G736 | ´ë»çÁúȯ¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in metabolic diseases |
 |
G736 | ±Û¸®ÄÚÁ¨ÃàÀûº´¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in glycogen storage disease(E74.0+) |
 |
G736 | ÁöÁúÃàÀûÀå¾Ö¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in lipid storage disorders(E75.-+) |
 |
G737 | ´Þ¸® ºÐ·ùµÈ ±âŸ Áúȯ¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in other diseases classified elsewhere |
 |
G737 | ·ù¸¶Æ¼½º°üÀý¿°¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in rheumatoid arthritis(M05-M06+) |
 |
G737 | ÇǺΰæÈÁõ¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in scleroderma (M34.8+) |
 |
G737 | °ÇÁ¶ÁõÈıº[½¦±×·»]¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in sicca syndrome[Sjogren](M35.0+) |
 |
G737 | Àü½Å¼º È«¹Ý·çǪ½º¿¡¼ÀÇ ±Ùº´Áõ | Myopathy in systemic lupus erythematosus(M32.1+) |
 |